Jonathan Gilbert
Craig Thomson
Craig has considerable experience in providing pragmatic, commercially focused advice to a wide-range of clients and in relation to biotechnological and pharmaceutical fields. As well as patent drafting and prosecution, Craig advises on the development of company-wide IP strategies, preparing for or carrying out funding/acquisition due diligence, and advising on aggressive/defensive strategies in relation to third party IP. He has a particular interest in inventions relating to the microbiome, including bacteriophage.
Artem Khlebnikov
Artem Khlebnikov is Strategic Partnerships Director at the Danone Nutricia Research. In his role, he works closely with public and private partners and Danone R&I colleagues brining open innovation to help drive science-based opportunities that activate the Danone’s alimentation strategy and enable significant and sustainable growth opportunities aligned with Danone’s #OneHealth.OnePlanet approach.
Artem holds an MS degree in Chemical Engineering from the Mendeleev University of Chemical Technology, Moscow Russia, has completed his PhD in Biotechnology at the Swiss Federal institute of Technology in Lausanne and received Post-Doctoral training in Molecular Biology at University of California at Berkeley, USA.
James Dening
James Murray
Tom Verlinden
Tom Verlinden obtained a Master in Pharmaceutical Science (University of Antwerp) and a master in Industrial Pharmacy (IPIL, France). Tom substantiated his knowledge at the EM Lyon business school and proceeded to work in a mid-sized pharmaceutical company (Production Manager at Gifrer et SEV, France). Tom has experience with leading/managerial positions, since he has many years of experience in management positions (Vice-président and COO) at Qualiphar (Belgium) and (Vice-président and Responsible Pharmacist) at Gifrer SAS (France).
Nichola Eliovits
Nick's investment expertise spans across asset classes with an extensive focus on microbiome oriented companies across all stages of venture capital.
Nick is a Managing Partner at Olive Tree Capital; he led his last company through acquisition and has successfully seeded and structured companies across multiple industries.
His passion for the Microbiome originates from personal experiences with fungal skin infections and c-diff.
Nick graduated with honors from Boston University’s Questrom School of Business and started his career in commodity markets at CPM Group in New York.
Alexander Gordon James
Gordon originates from Glasgow in Scotland, and was educated at University of Glasgow, graduating with a BSc and PhD in Biochemistry in 1987 and 1991, respectively. He then did a postdoctoral fellowship at University of Strathclyde in the area of environmental biotechnology, during which time he began practicing his favoured discipline of microbial biochemistry. Gordon joined Unilever R&D in 1993, and in the time since, his main focus has been using his microbial biochemistry skills to unravel the origins of axillary (underarm) odour. His current role is to provide scientific leadership to a UK-based team specialising in this topic on behalf of Unilever’s Deodorants category and the global Science & Technology Platform, Human Microbiome